Mashup Score: 2 library.ehaweb.org NO DIFFERENCE IN OVERALL SURVIVAL BETWEEN R-CHOP AND R-EPOCH AMONG… by Tylan Magnusson - EHA Library; Magnusson T. Jun 9 2021; 324632; 123456 Akiva Diamond Retrospective Flatiron EMR data presented at EHA2021 showed no difference in OS in 154 DH/THL patients treated with RCHOP vs EPOCH. 4 years OS was 54.5% vs vs. 49.6%, respectively. Single hit MYC-R patients had even worse outcomes. Read the full article here See more from Akiva Diamond Share this article × facebook twitter email https://mashupmd.com/expert-articles-post/no-difference-in-overall-survival-between-r-chop-and-r-epoch-among-by-tylan-magnusson/ Copy Link
apple.news Disturbing Discovery Finds That Space Does Something Bad to Astronauts' Bones — Fu... Wafik S. El-Deiry, MD, PhD, FACP, FRSM
OncLive Capivasertib Plus Docetaxel Continues to Demonstrate Improved Overall Survival in ... #pcsm OncLive.com
www.thetimes.co.uk Surgeon assaulted on ward demands more transparency to tackle sexual misconduct Ash Paul
the Guardian Women accused of illegal abortions in England and Wales after miscarriages and sti... Ash Paul
The Times of India Doctors as selfless gods? Urban elite created this myth, especially movies, says D... Ash Paul
The George Institute for Impact: The George Institute’s research informs Australian govt advice on e-cigare... Ash Paul
the Guardian Why are we feeding crops to our cars when people are starving? | George Monbiot Ash Paul
OncLive Monk Breaks Down Recent Advances Across the Gynecologic Cancer Paradigm #gyncsm #ovca OncLive.com
jamanetwork.com Analysis of COVID-19–Related Croup and SARS-CoV-2 Variant Predominance in the US Antonio Pagliuca
OncLive Pembrolizumab/Chemo With or Without Bevacizumab Has Potential as New SOC in Metast... #oncology #ovca OncLive.com
Retrospective Flatiron EMR data presented at EHA2021 showed no difference in OS in 154 DH/THL patients treated with RCHOP vs EPOCH. 4 years OS was 54.5% vs vs. 49.6%, respectively. Single hit MYC-R patients had even worse outcomes.